From pairwise to network meta-analyses

Network Meta-Analysis: Evidence Synthesis with Mixed Treatment Comparison

Volumn , Issue , 2014, Pages 21-41

  Snedecor, Sonya J ^a   Patel, Dipen A ^a   Cappelleri, Joseph C ^b  

^a PHARMERIT INTERNATIONAL   (United States)

^b PFIZER INC   (United States)

Author keywords

Direct evidence; evidence networks; history; indirect evidence; indirect treatment comparisons; meta analysis applications; mixed treatment comparison; network meta analysis

Indexed keywords

EID: 84957614954     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (82)

1. nd ed. New York: Russell Sage Foundation; 2009.
2. Glass GV. Primary, Secondary, and Meta-Analysis of Research. Educational Researcher 1976; 5: 3-8.
3. O'Rourke K. An historical perspective on meta-analysis: dealing quantitatively with varying study results. J. R. Soc. Med. 2007; 100: 579-82.
4. Pearson K. Report on Certain Enteric Fever Inoculation Statistics. BMJ 1904; 2: 1243-6.
5. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
6. Jones DR. Meta-analysis: weighing the evidence. Stat. Med. 1995; 14: 137-49.
7. Elwood PC, Cochrane AL, Burr ML, Sweetnam PM, Williams G, Welsby E, Hughes SJ, Renton R. A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. BMJ 1974; 1: 436-40.
8. Elwood P. The first randomized trial of aspirin for heart attack and the advent of systematic overviews of trials. J. R. Soc. Med. 2006; 99: 586-8.
9. Chalmers TC, Matta RJ, Smith H, Jr., Kunzler AM. Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. New Engl. J. Med. 1977; 297: 1091-6.
10. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog. Cardiovasc. Dis. 1985; 27: 335-71.
11. Pandis N. The evidence pyramid and introduction to randomized controlled trials. Am. J. Orthod. Dentofacial. Orthop. 2011; 140: 446-7.
12. Berman NG, Parker RA. Meta-analysis: neither quick nor easy. BMC Med. Res. Methodol 2002; 2: 10.
13. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Deveraux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann. Intern. Med. 2009; 151: W65-94.
14. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analyses of randomized controlled trials. New Engl. J. Med. 1987; 316: 450-5.
15. nd edition. New York: Russell Sage Foundation; 2009.
16. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]: The Cochrane Collaboration; 2011.
17. Borenstein M. Introduction to Meta-Analysis. Chichester: John Wiley & Sons; 2009.
18. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Nat. Cancer Inst. 1959; 22: 719-48.
19. Wolf FM. Meta-analysis: quantitative methods for research synthesis: New York: Sage Publications; 1986.
20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin. Trials. 1986; 7: 177-88.
21. Petitti DB. Meta-analysis, decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine. 2nd ed. New York: Oxford University Press; 2000.
22. Shadish WR, Haddock CK. Combining estimates of effect size. In: Cooper H, Hedges LV, Valentine JC, editors. The Handbook of Research Synthesis and Meta-Analysis. 2nd ed. New York, NY: Russell Sage Foundation; 2009.
23. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Methods for Meta-Analysis in Medical Research. London: John Wiley & Sons; 2000.
24. Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med. Decis Making 2013; 33: 607-17.
25. Jansen JP, Fleurence R, Devine B, Itzler R, Barrett A, Hawkins N, Lee K, Boersma C, Annemans L, Cappelleri JC. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health 2011; 14: 417-28.
26. Parker M. Foundations of Statistics - Frequentist and Bayesian 2004 2/2/2014. Available from: http://www.austincc.edu/mparker/stat/nov04/talk_nov04.pdf (last accessed on February 9, 2014).
27. Sutton AJ, Higgins JP. Recent developments in meta-analysis. Stat. Med. 2008; 27: 625-50.
28. Lau J, Ioannidis JP, Schmid CH. Summing up evidence: one answer is not always enough. Lancet 1998; 351: 123-7.
29. Spiegelhalter DJ, Best NG, Carlin BP, Van Der Linde A. Bayesian measures of model complexity and fit. Journal of the Royal Statistical Society: Series B (Statistical Methodology) 2002;64:583-639.
30. US Food and Drug Administration CDER2013139 White Paper2013 1/21/2014. Available from: www.fda.gov/downloads/Drugs/NewsEvents/UCM372069.pdf (last accessed on February 9, 2014).
31. Berlin JA, Crowe BJ, Whalen E, Xia HA, Koro CE, Kuebler J. Meta-analysis of clinical trial safety data in a drug development program: answers to frequently asked questions. Clin Trials 2013; 10: 20-31.
32. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts: Treatments for myocardial infarction. JAMA 1992; 268: 240-8.
33. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction. New Engl. J. Med. 1992; 327: 248-54.
34. Cappelleri JC, Ioannidis JPA, Lau J. Meta-Analysis of Therapeutic Trials. In: Chow S-C, editor. Encyclopedia of Biopharmaceutical Statistics. New York: Informa Healthcare; 2010.
35. Dias S, Sutton AJ, Welton NJ, Ades AE. Evidence synthesis for decision making 6: embedding evidence synthesis in probabilistic cost-effectiveness analysis. Med. Decis Making 2013; 33: 671-8.
36. Ades AE, Sculpher M, Sutton A, Abrams K, Cooper N, Welton N, et al. Bayesian methods for evidence synthesis in cost-effectiveness analysis. Pharmacoeconomics 2006; 24: 1-19.
37. Cappelleri JC, Network meta-analysis for comparative effectiveness research. Presented at 19th Annual Biopharmaceutical Applied Statistics Symposium, Savannah, GA., 2012.
38. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J. Clin. Epidemiol. 1997; 50: 683-91.
39. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat. Med. 2002; 21: 2313-24.
40. Song F, Altman DG, Glenny AM, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ 2003; 326: 472.
41. Salanti G, Higgins JP, Ades AE, Ioannidis JP. Evaluation of networks of randomized trials. Stat. Methods Med. Res. 2008; 17: 279-301.
42. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat. Med. 2004; 23: 3105-24.
43. Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 2005; 331: 897-900.
44. Felson DT, Anderson JJ, Meenan RF. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two meta-analyses. Arthritis. Rheum. 1990; 33: 1449-61.
45. O'Brien BJ, Anderson DR, Goeree R. Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement. CMAJ 1994; 150: 1083-90.
46. Song F, Loke YK, Walsh T, Glenny AM, Eastwood AJ, Altman DG. Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. BMJ 2009; 338: b1147.
47. Chou R, Carson S, Chan BK. Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: discrepancies between direct and indirect meta-analyses of randomized controlled trials. J. Gen. Intern. Med. 2009; 24: 178-88.
48. Chapple CR, Khullar V, Gabriel Z, Muston D, Bitoun CE, Weinstein D. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur. Urol. 2008; 54: 543-62.
49. Dias S, Welton NJ, Sutton AJ, Ades AE. Evidence synthesis for decision making 1: introduction. Med. Decis Making 2013; 33: 597-606.
50. Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE. Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials. Med. Decis. Making 2013; 33: 641-56.
51. Cooper NJ, Peters J, Lai MC, Juni P, Wandel S, Palmer S, Paulden M, Conti S, Welton NJ, Abrams KR, Bujkiewicz S, Spiegelhalter D, Sutton AJ. How valuable are multiple treatment comparison methods in evidence-based health-care evaluation? Value Health 2011; 14: 371-80.
52. Hoaglin DC, Hawkins N, Jansen JP, Scott DA, Itzler R, Cappelleri JC, Boersma C, Thompson D, Larholt KM, Diaz M, Barrett A. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. Value Health 2011; 14: 429-37.
53. Donegan S, Williamson P, Gamble C, Tudur-Smith C. Indirect comparisons: a review of reporting and methodological quality. PloSone 2010; 5: e11054.
54. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat. Med 2002; 21: 1539-58.
55. Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10: 101-29.
56. Cooper NJ, Sutton AJ, Morris D, Ades AE, Welton NJ. Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. Stat. Med. 2009; 28: 1861-81.
57. Salanti G, Kavvoura FK, Ioannidis JP. Exploring the geometry of treatment networks. Ann. Intern. Med. 2008; 148: 544-53.
58. Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat. Med. 2010; 29: 932-44.
59. Lu G, Ades AE. Assessing Evidence Inconsistency in Mixed Treatment Comparisons. J. Am. Stat. Assoc. 2006; 101: 447.
60. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat. Med. 1999; 18: 2693-708.
61. Christensen R. Beyond RefMan: Meta-regression analysis in context: The Cochrane Collaboration; 2014. Available from: http://musculoskeletal.cochrane.org/sites/ musculoskeletal.test.cochrane.org/files/uploads/RC_Lecture.pdf (last accessed on February 9, 2014).
62. Baker WL, White CM, Cappelleri JC, Kluger J, Coleman CI; Health Outcomes, Policy, and Economics (HOPE) Collaborative Group. Understanding heterogeneity in meta-analysis: the role of meta-regression. Int. J. Clin. Pract. 2009; 63: 1426-34.
63. Riley RD, Lambert PC, Staessen JA, Wang J, Gueyffier F, Thijs L, Boutitie F. Meta-analysis of continuous outcomes combining individual patient data and aggregate data. Stat. Med. 2008; 27: 1870-93.
64. th Annual International Meeting, New Orleans, LA, 2013.
65. Signorovitch JE, Wu EQ, Yu AP, Gerrits CM, Kantor E, Bao Y, Gupta SR, Mulani PM. Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept. Pharmacoeconomics 2010; 28: 935-45.
66. nd ed. New York, NY: Russell Sage Foundation; 2009.
67. Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin. Trials 1995; 16: 62-73.
68. Balk EM, Bonis PA, Moskowitz H, Schmid CH, Ioannidis JP, Wang C, Lau J. Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA 2002; 287: 2973-82.
69. Halpern SD, editor. Evidence-based Obstetric Anesthesia. Oxford: Blackwell Publishing; 2007.
70. Abdelhamid AS, Loke YK, Parekh-Bhurke S, Chen Y-F, Sutton A, Eastwood A. Use of indirect comparison methods in systematic reviews: a survey of Cochrane review authors. Research Synthesis Methods 2012; 3: 71-9.
71. Song F, Xiong T, Parekh-Bhurke S, Loke YK, Sutton AJ, Eastwood AJ, Holland R, Chen YF, Glenny AM, Deeks JJ, Altman DG. Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study. BMJ 2011; 343: d4909.
72. Achana FA, Cooper NJ, Dias S, Lu G, Rice SJ, Kendrick D, Sutton AJ. Extending methods for investigating the relationship between treatment effect and baseline risk from pairwise meta-analysis to network meta-analysis. Stat. Med. 2013; 32: 752-71.
73. Jackson D, Riley R, White IR. Multivariate meta-analysis: Potential and promise. Stat. Med. 2011; 30: 2481-98.
74. Riley RD. Multivariate meta-analysis: the effect of ignoring within-study correlation. Journal of the Royal Statistical Society: Series A (Statistics in Society) 2009; 172: 789-811.
75. Riley RD, Abrams KR, Lambert PC, Sutton AJ, Thompson JR. An evaluation of bivariate random-effects meta-analysis for the joint synthesis of two correlated outcomes. Stat. Med. 2007; 26: 78-97.
76. Nam IS, Mengersen K, Garthwaite P. Multivariate meta-analysis. Stat. Med. 2003; 22: 2309-33.
77. Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J. Clin. Epidemiol. 1991; 44: 1271-8.
78. Oxman AD, Guyatt GH, Singer J, Goldsmith CH, Hutchison BG, Milner RA, Streiner DL. Agreement among reviewers of review articles. J. Clin. Epidemiol. 1991; 44: 91-8.
79. Council NR. Finding What Works in Health Care: Standards for Systematic Reviews. In: Eden J, Levit L, Berg A, Morton S, editors. Washington: The National Academies Press; 2011.
80. Ades AE, Caldwell DM, Reken S, Welton NJ, Sutton AJ, Dias S. Evidence synthesis for decision making 7: a reviewer's checklist.Med. Decis. Making 2013; 33:679-91.
81. Jansen JP, Trikalinos T, Cappelleri JC, Daw J, Andes S, Eldessouki R, Salanti G. Indirect treatment comparison/network meta-analysis study questionnaire to assess relevance and credibility to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report. Value Health. 2014; 17:157-73.
82. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-YtterY, Glasziou P, DeBeer H, Jaeschke R, Rind D, Meerpohl J, Dahm P, Schunemann HJ. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J. Clin. Epidemiol. 2011; 64: 383-94.